Company Information
CIN
Status
Date of Incorporation
24 July 1971
Listing Status
Unlisted
State
Gwalior
ROC
ROC Gwalior
Industry
Diagnostic, Pathological Laboratories
Sub Category
Non-govt company
Last Balance Sheet
31 March 2023
Last Annual Meeting
31 October 2023
Paid Up Capital
16,776,000
Authorised Capital
20,000,000
Financials All Documents available from MCA @Rs 199/-
Directors
Pankaj Badlani
Director
about 1 year ago
about 1 year ago
Mahesh Badlani
Director
over 1 year ago
over 1 year ago
Subhash Rijhwani
Director/Designated Partner
over 1 year ago
over 1 year ago
Past Directors
Jairamdas Badlani
Director
almost 43 years ago
almost 43 years ago
Registered Trademarks
[Class : 5] Pharmaceutical Products, Medicines.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical Products, Medicines.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical Products, Medicines Included In Class 5.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +6 more Brands for Promed Laboratories Private Limited.
Charges
09 September 2016
Kotak Mahindra Bank Limited
3 Crore
06 September 2005
Bank Of Baroda
8 Crore
28 July 2005
Bank Of Baroda
5 Crore
09 September 2016
Others
0
06 September 2005
Bank Of Baroda
0
28 July 2005
Bank Of Baroda
0
09 September 2016
Others
0
06 September 2005
Bank Of Baroda
0
28 July 2005
Bank Of Baroda
0
Documents
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-04122023
Supplementary or Test audit report under section 143-04122023
Form AOC - 4 CFS-04122023
Approval letter of extension of financial year or AGM-02122023
Directors report as per section 134(3)-02122023
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-02122023
Form AOC-4-02122023_signed
Form AOC-4-08092023_signed
Directors report as per section 134(3)-05012023
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-05012023
Supplementary or Test audit report under section 143-11012023
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-11012023
Form AOC - 4 CFS-11012023_signed
Form MGT-7A-08122022_signed
List of Directors;-03122022
List of share holders, debenture holders;-03122022
Approval letter for extension of AGM;-14032022
Supplementary or Test audit report under section 143-14032022
List of share holders, debenture holders;-14032022
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-14032022
List of Directors;-14032022
Form MGT-7A-17032022_signed
Form AOC - 4 CFS-17032022_signed
Form DPT-3-11032022_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-09032022
Approval letter of extension of financial year or AGM-09032022
Directors report as per section 134(3)-09032022